[Seasonal influenza in children - the underestimated problem]

Aneta Nitsch-Osuch1, Agnieszka Woźniak Kosek, Lidia Bemadeta Brydak

  • 1Katedra i Zakład Medycyny Rodzinnej z Oddziałem Klinicznym Chorób WewnEtrznych i Metabolicznych, Warszawski Uniwersytet Medyczny. anitsch@amwaw.edu.pl

Przeglad Lekarski
|May 8, 2013
PubMed

Insights

Influenza poses a significant health and economic burden in children, with low vaccination rates in Poland. Increasing influenza vaccination coverage is crucial for preventing illness and complications in pediatric populations.

Area of Science:

  • Pediatrics
  • Epidemiology
  • Public Health

Background:

  • Influenza is an underestimated clinical, epidemiological, and economic problem in children.
  • Febrile respiratory infections in children are often attributed to influenza (10-40% annually).
  • Pediatric influenza incidence is higher than in the general population, particularly in Poland.

Purpose of the Study:

  • To review current knowledge on pediatric influenza epidemiology, focusing on Poland.
  • To assess the impact of influenza on healthcare utilization (ambulatory visits, hospitalizations).
  • To highlight the clinical and economic benefits of influenza vaccination in children.

Main Methods:

  • Literature review on influenza epidemiology in children.
  • Analysis of influenza impact on healthcare systems.
  • Evaluation of vaccination effectiveness and safety.

Main Results:

  • Influenza incidence is elevated in Polish children (<14 years) compared to the general population.
  • Vaccine coverage in Polish children (<5 years) is critically low (<2%).
  • Influenza vaccination is effective and safe, protecting both vaccinated children and their contacts.

Conclusions:

  • Vaccination is the primary prevention method for influenza in children and adolescents (6 months-18 years).
  • Despite recommendations since 1994, influenza vaccination coverage in Polish children remains insufficient.
  • Enhanced educational initiatives for the public and healthcare providers are needed to improve vaccination rates.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccinations01:51

Vaccinations

Overview
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...